open access

Ahead of Print
Research paper
Published online: 2022-12-02
Get Citation

Clinical significance of bladder training in preoperative localization of high-intensity focused ultrasound ablation of uterine fibroids

Xiaofei He12, Sha Liao12
DOI: 10.5603/GP.a2022.0142
·
Pubmed: 36477779
Affiliations
  1. Department of Operating Room Nursing, West China Second University Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, Sichuan, China
  2. Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China

open access

Ahead of Print
ORIGINAL PAPERS Gynecology
Published online: 2022-12-02

Abstract

Objectives: High-intensity focused ultrasound (HIFU) is widely used to treat uterine fibroids. HIFU preoperative localization of uterine fibroids can be used to determine whether the patient is a suitable candidate for HIFU treatment. This study investigated the clinical significance of bladder training in improving the success rate of HIFU preoperative localization uterine fibroids.

Material and methods: Our sample consists of patients who planned to undergo HIFU treatment in our hospital but who were failed in previous HIFU preoperative localization. They were recruited between July 2021 and April 2022, and randomly divided into experimental and control groups. A total of 150 patients were enrolled. Each group consisted of 75 patients. The patients in the experimental group adopted the procedure of drinking water multiple times and retaining urine. The training program lasted three days. The patients in the control group were required to keep regular drinking and urination habits without any special instructions or requirements.

Results: There were no statistically significant differences between the two groups in maximum bladder capacity, residual urine volume of bladder, bladder filling levels, and bladder shape change. After bladder training, the maximum bladder capacity and the degree bladder shape change of the patients in the experimental group were improved significantly. The success rate of HIFU preoperative localization in the patients in the experimental group was significantly higher than that of the control group.

Conclusions: Bladder training can effectively improve the success rate of HIFU preoperative localization of uterine fibroids.

Abstract

Objectives: High-intensity focused ultrasound (HIFU) is widely used to treat uterine fibroids. HIFU preoperative localization of uterine fibroids can be used to determine whether the patient is a suitable candidate for HIFU treatment. This study investigated the clinical significance of bladder training in improving the success rate of HIFU preoperative localization uterine fibroids.

Material and methods: Our sample consists of patients who planned to undergo HIFU treatment in our hospital but who were failed in previous HIFU preoperative localization. They were recruited between July 2021 and April 2022, and randomly divided into experimental and control groups. A total of 150 patients were enrolled. Each group consisted of 75 patients. The patients in the experimental group adopted the procedure of drinking water multiple times and retaining urine. The training program lasted three days. The patients in the control group were required to keep regular drinking and urination habits without any special instructions or requirements.

Results: There were no statistically significant differences between the two groups in maximum bladder capacity, residual urine volume of bladder, bladder filling levels, and bladder shape change. After bladder training, the maximum bladder capacity and the degree bladder shape change of the patients in the experimental group were improved significantly. The success rate of HIFU preoperative localization in the patients in the experimental group was significantly higher than that of the control group.

Conclusions: Bladder training can effectively improve the success rate of HIFU preoperative localization of uterine fibroids.

Get Citation

Keywords

leiomyoma; uterus; high-intensity focused ultrasound ablation; urinary bladder

About this article
Title

Clinical significance of bladder training in preoperative localization of high-intensity focused ultrasound ablation of uterine fibroids

Journal

Ginekologia Polska

Issue

Ahead of Print

Article type

Research paper

Published online

2022-12-02

Page views

90

Article views/downloads

58

DOI

10.5603/GP.a2022.0142

Pubmed

36477779

Keywords

leiomyoma
uterus
high-intensity focused ultrasound ablation
urinary bladder

Authors

Xiaofei He
Sha Liao

References (19)
  1. Sparic R, Mirkovic L, Malvasi A, et al. Epidemiology of uterine myomas: a review. Int J Fertil Steril. 2016; 9(4): 424–435.
  2. Ming WK, Wu H, Wu Y, et al. Health-related quality of life in pregnancy with uterine fibroid: a cross-sectional study in China. Health Qual Life Outcomes. 2019; 17(1): 89.
  3. El-Balat A, DeWilde RL, Schmeil I, et al. Modern myoma treatment in the last 20 years: a review of the literature. Biomed Res Int. 2018; 2018: 4593875.
  4. Zhang L, Zhang W, Orsi F, et al. Ultrasound-guided high intensity focused ultrasound for the treatment of gynaecological diseases: A review of safety and efficacy. Int J Hyperthermia. 2015; 31(3): 280–284.
  5. Lee KW. The Asian perspective on HIFU. Int J Hyperthermia. 2021; 38(2): 5–8.
  6. Napoli A, Alfieri G, Andrani F, et al. Uterine myomas: focused ultrasound surgery. Semin Ultrasound CT MR. 2021; 42(1): 25–36.
  7. Ter Haar G. HIFU tissue ablation: concept and devices. Adv Exp Med Biol. 2016; 880: 3–20.
  8. Liu Lu, Wang T, Lei B. Ultrasound-guided microwave ablation in the management of symptomatic uterine myomas: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2021; 28(12): 1982–1992.
  9. Bohlmann MK, Hoellen F, Hunold P, et al. High-Intensity focused ultrasound ablation of uterine fibroids - potential impact on fertility and pregnancy outcome. Geburtshilfe Frauenheilkd. 2014; 74(2): 139–145.
  10. Ierardi AM, Carnevale A, Pellegrino F, et al. Uterine myomas: extravascular treatment. Semin Ultrasound CT MR. 2021; 42(1): 56–74.
  11. Zhou YF. High intensity focused ultrasound in clinical tumor ablation. World J Clin Oncol. 2011; 2(1): 8–27.
  12. Mahmoud MZ, Alkhorayef M, Alzimami KS, et al. High-Intensity focused ultrasound (HIFU) in uterine fibroid treatment: review study. Pol J Radiol. 2014; 79: 384–390.
  13. Zhang L, Wang ZB. High-intensity focused ultrasound tumor ablation: review of ten years of clinical experience. Front Med China. 2010; 4(3): 294–302.
  14. Siedek F, Yeo SY, Heijman E, et al. Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU): technical background and overview of current clinical applications (Part 1). Rofo. 2019; 191(6): 522–530.
  15. Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev. 2004; 84(3): 935–986.
  16. Aoki Y, Brown HW, Brubaker L, et al. Urinary incontinence in women. Nat Rev Dis Primers. 2017; 3: 17042.
  17. Tykocki NR, Monson FC. Excitability and contractility in arterioles and venules from the urinary bladder. Curr Top Membr. 2020; 85: 301–326.
  18. Birder LA. Urinary bladder, cystitis and nerve/urothelial interactions. Auton Neurosci. 2014; 182: 89–94.
  19. Ker CR, Ou KY, Long CY, et al. Acute renal insufficiency and thrombocytopenia after high-intensity focused ultrasound (HIFU) ablation for uterine myomas. Taiwan J Obstet Gynecol. 2020; 59(4): 594–597.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl